Eli Lilly wants the public to know it’s more than just a manufacturer of GLP-1 drugs. Demand for its “diabesity” drugs, Zepbound and Mounjaro, has skyrocketed in recent years, coinciding with a ...

The story of Eli Lilly has, at least recently, been a triumphant one. Thanks to the popularity of its drug for type 2 diabetes, Mounjaro, and that medicine's sibling drug for weight loss, Zepbound, ...

U.S. equities were little changed at midday as the market had little news that would move stocks very much either way. Eli Lilly said its weight-loss pill met primary and key secondary endpoints in a ...

Complete Eli Lilly & Co. stock information by Barron's. View real-time LLY stock price and news, along with industry-best analysis.